Cargando…
Successful capecitabine rechallenge following 5-fluorouracil-induced Takotsubo syndrome
Cardiac toxicity is a widely reported complication of fluoropyrimidine chemotherapies (5-fluorouracil and capecitabine); however, Takotsubo syndrome (TS) is less widely reported. There is little data available describing the viability of fluoropyrimidine rechallenge after fluoropyrimidine-induced TS...
Autores principales: | Abdelrahman, Mohamed, McCarthy, Michael T., Yusof, Haliana, Osman, Nemer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794555/ https://www.ncbi.nlm.nih.gov/pubmed/26989494 http://dx.doi.org/10.1093/omcr/omv072 |
Ejemplares similares
-
5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020) -
Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge
por: Medepalli, Lalitha C, et al.
Publicado: (2022) -
Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter
por: Lim, Stephanie Hui-Su, et al.
Publicado: (2013) -
A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine
por: Chahin, Michael, et al.
Publicado: (2020) -
Rechallenge capecitabine after fluoropyrimidine-induced cardiotoxicity in rectal cancer: A case report
por: Peng, Tao, et al.
Publicado: (2019)